Acute Management of Symptomatic Subependymal Giant Cell Astrocytoma With Everolimus

Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis

Darcy A. Krueger, Marguerite M. Caré, Katherine Holland et al. · New England Journal of Medicine · 2010 · 1K citations · Full text

Medicine, Neurological Surgery, Neurology +13

Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

Darcy A. Krueger, Hope Northrup, Hope Northrup et al. · Pediatric Neurology · 2013 · 860 citations · Full text

Medicine, Neurology, Pediatrics +11

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

David Neal Franz, Steven Sparagana, E. Martina Bebin et al. · The Lancet · 2012 · 784 citations

Medicine, Neurology, Oncology +10

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study

Jacqueline A. French, John A. Lawson, Hiroko Ikeda et al. · The Lancet · 2016 · 747 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Subependymal Giant Cell Astrocytoma: Diagnosis, Screening, and Treatment. Recommendations From the International Tuberous Sclerosis Complex Consensus Conference 2012

Jonathan Roth, E. Steve Roach, Ute Bartels et al. · Pediatric Neurology · 2013 · 211 citations · Full text

Medicine, Neurological Surgery, Neurology +12